SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BioLase Technology, Inc. (BLTI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: pete duda who wrote (66)5/15/1997 1:11:00 PM
From: BigMoney   of 706
 
This was in their last press release:

``The first quarter, as expected, was a period of stepped-up activity in preparation for the
introduction of two major BIOLASE products,'' said Donald A. La Point, president and chief
executive offiecer of BIOLASE.

``In particular, we established the resources necessary to begin shipping the first of our proprietary
Millennium(tm) (HydroKinetic(tm) Tissue Cutting System) surgical devices under a $12 million
minimum purchase agreement with our German distributor, Orbis High Tech Dental GmbH.

--

That's $12 million MINIMUM, and that's just in Germany. Compare that to the piddly sales they have now on their old products.
First quarter 1997 results were $134,405 in revenues, with a loss of $767,734 so total expenses was around $900.000.
Sales are going to skyrocket next quarter, and earnings with it. Sales will be in the millions. That's one fact that's going to
be hard to ignore. Who cares what their 10-K, or 10-Q looks like now. Next 10-Q will make your eyes bug out.
This company has no debt, which means all of it belongs to the stockholders who get to reap the entire benefit.

Anyways, these are just my opinions. So... get ready for the next run up.

BigMama
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext